HOME >> BIOLOGY >> NEWS
Pall filtration technology verified to remove arsenic from drinking water

1,300 non-community water systems will need to take measures to lower arsenic in their drinking water.

Membrane filtration technology is emerging as the technology of choice for safe drinking water. Large and small communities around the world currently use the Pall Aria System to remove parasites, including cryptosporidia and giardia cysts and oocysts that can contaminate drinking water and adversely affect public health. The new verification enables these communities to remove both arsenic and parasites cost efficiently. The Pall system is also employed by a wide range of industries to clean up wastewater to prevent additional arsenic from entering the drinking water supply.

Unlike other methods of arsenic removal, such as reverse osmosis and adsorption media, membrane filtration offers a less costly and long-term solution. It does not require a major upfront capital investment, high costs to operate or frequent regeneration and purchase of media. The Pall Aria System works by the addition of an iron-based coagulant, such as ferric chloride, to the water. The contaminating arsenic is adsorbed onto positively charged ferric hydroxide particles, which are then removed by microfiltration.

"The arsenic removal verification opens up a whole new market for Pall Water Processing, which is currently one of the fastest growing businesses of Pall Corporation. This past year our sales to municipal and community water systems have grown over 26 percent," adds Mr. Seibert.

Arsenic Hot Spots and Public Health Implications

Arsenic levels across the U.S. can vary greatly. Although there are some geographic hot spots, the highest arsenic levels in the U.S. are found mostly in states west of the continental divide. However, several New England states such as New Hampshire and Maine have reported that as many as 30% and 14%, respectively, of their public water systems have arsenic levels above the new standard.

Arse
'"/>

Contact: Marcia Katz
Marcia_Katz@pall.com
516-801-9128
Pall Corporation
6-Dec-2005


Page: 1 2 3

Related biology news :

1. Carbon capture, water filtration, other boreal forest ecoservices worth estimated $250 billion/year
2. Water filtration technique removes dangerous freshwater algae toxins
3. Pall blood filtration technology removes prions that can cause TSEs
4. AFCYBER holds science and technology symposium
5. New technology reveals seal behavior
6. Nanotechnology helps scientists make bendy sensors for hydrogen vehicles
7. FDA Nanotechnology Task Force takes positive step forward
8. Liverpool amongst first in UK to install unique DNA sequencing technology
9. EPA foregoes opportunity to improve nanotechnology oversight
10. The Cancer Genome Atlas awards funds for technology development
11. Autism theory put to the test with new technology

Post Your Comments:
(Date:11/21/2014)... 20, 2014 C-Labs LLC, a leading provider ... Things (IoT), today announced the appointment of John ... Previously a strategic advisor to the firm, Mr. Traynor ... Traynor is based out of the C-Labs office in ... Chris Muench , Chief Executive Officer. ...
(Date:11/18/2014)... 2014   EyeLock Inc. , a market ... MorphoTrust USA (Safran), a leading U.S. provider ... strategic partnership to offer comprehensive biometric identity solutions ... airport screening and financial services markets. ... consumers through a nationwide network of 1,100 IdentoGO® ...
(Date:11/7/2014)... professor, biomedical engineering, in the Grove School of ... have identified a molecule that could lead to ... forms of breast cancer. , Triple negative breast ... to aggressive proliferation and metastasis and a lack ... discovered the overexpression of intercellular adhesion molecule-1 (ICAM-1) ...
Breaking Biology News(10 mins):C-Labs Names Former Microsoft and Bsquare Executive as Chief Operating Officer 2EyeLock, MorphoTrust Form Strategic Partnership to Pursue Commercial Enterprise Deployments 2EyeLock, MorphoTrust Form Strategic Partnership to Pursue Commercial Enterprise Deployments 3
(Date:11/21/2014)... The report, "Synthetic Biology ... Cloning kits), Technology (Bioinformatics, Nanotechnology, Gene Synthesis, ... Bioremediation) - Global Forecast to 2018", analyses ... opportunities, and challenges. , Browse 99 market ... 185 pages and in-depth TOC of the ...
(Date:11/21/2014)... Arkansas (PRWEB) November 20, 2014 ... Pinnacle Ozone Solutions, LLC (Pinnacle), and PCI, Inc., ... announced that they have been selected to provide ... of Fayetteville, Arkansas Paul R. Noland Wastewater Treatment. ... BlueInGreen’s patented HyDOZ® gas dissolution technology, ...
(Date:11/21/2014)... Dallas, Texas (PRWEB) November 21, 2014 ... China Sodium Ferrocyanide Industry” is a professional and ... it provides Sodium ferrocyanide information, like its ... well as industry overview. This report covers the ... well as global (such as the US, Europe, ...
(Date:11/21/2014)... DIEGO , Nov. 20, 2014 ... has been dosed in its Phase 1 trial ... cisplatin for the treatment of malignant pleural mesothelioma ... Group is conducting clinical trials on ADI-PEG 20, ... agents, for the treatment of several other indications, ...
Breaking Biology Technology:Synthetic Biology Market Expected to Reach $5,630.4 Million in 2018 - New Report by MarketsandMarkets 2Synthetic Biology Market Expected to Reach $5,630.4 Million in 2018 - New Report by MarketsandMarkets 3Synthetic Biology Market Expected to Reach $5,630.4 Million in 2018 - New Report by MarketsandMarkets 4City of Fayetteville Leads Nation with Innovative Ozone Technology 2City of Fayetteville Leads Nation with Innovative Ozone Technology 3City of Fayetteville Leads Nation with Innovative Ozone Technology 4Sodium Ferrocyanide Market: Analysis for Global & China Regions Development Trends Available at DeepResearchReports.com 2Sodium Ferrocyanide Market: Analysis for Global & China Regions Development Trends Available at DeepResearchReports.com 3Polaris Group Announces Treatment of First Patient in Phase 1 Study of ADI-PEG 20 plus Pemetrexed and Cisplatin in Malignant Pleural Mesothelioma And Non-Squamous Non-Small Cell Lung Carcinoma 2
Cached News: